Asahi Kasei Bioprocess (AKB) and Axolabs News and Resources

Asahi Kasei Bioprocess (AKB), a part of the Asahi Kasei Group, and Axolabs have announced their partnership to construct a new oligonucleotide cGMP manufacturing facility in Berlin. The facility, spanning an impressive 59,000 square feet, is a significant step towards